What is the Drépa-FACETS program studying for sickle cell disease?

The Drépa-FACETS program is being studied to see if it can help adults with sickle cell disease manage fatigue by combining therapy and energy-saving strategies. Researchers want to understand if this adapted program is practical and beneficial for patients living with this condition, supported by Versailles Hospital.

Who may be eligible for this sickle cell disease clinical trial?

Adults aged 18 years or older with a major sickle cell syndrome diagnosis who can speak and write French may be eligible. People with severe psychiatric conditions, other chronic fatigue-causing illnesses, or those currently hospitalized are not eligible. Please review eligibility criteria for more details.

Is there any cost to participate in this sickle cell disease clinical trial?

Study-related care, including the program and all trial visits, is provided at no cost. However, personal travel expenses may vary and are not guaranteed to be covered.

Actively Recruiting

Phase Not Applicable

Age: 18Years +

All Genders

ID06650813

Adapting the FACETS Fatigue Management Program for Adults with Sickle Cell Disease

Led by Versailles Hospital · Updated on 2025-08-19

Participants Needed

Research Sites

N/A

Total Duration

AI-Summary

What this Trial Is About

This research aims to adapt a fatigue management program called the FACETS program, which combines cognitive-behavioral therapy and energy conservation techniques, specifically for adult patients living with sickle cell disease. The study focuses on evaluating the feasibility of this adapted program, named Drpa-FACETS, for managing fatigue symptoms in this population. Participants will take part in the Drpa-FACETS program designed for sickle cell disease. The program includes sessions and home exercises tailored to help manage fatigue. The study will monitor participants from enrollment through the end of the protocol visits over a 10-week period. During the study, participants will complete assessments and questionnaires to measure fatigue and their ability to follow the program. The research team will evaluate how well the program works for adults with sickle cell disease by tracking adherence and outcomes related to fatigue management over the course of the study.

CONDITIONS

Brief Title

Adapting the FACETS Program to Sickle Cell Disease

Who Can Participate

Age: 18Years +

All Genders

Eligibility Criteria

You may qualify if you...

Participant having freely given his oral agreement.
Participant with a major sickle cell syndrome, regardless of genotype (e.g. SS, SC, Sbeta).
Participant with a sufficient command of spoken and written French to take the assessments, complete the questionnaires, follow the program sessions and carry out the home exercises.

You will not qualify if you...

Participant with one or more severe psychiatric pathologies (e.g. severe depression, psychosis) that could interfere with the conduct of the study.
Participants with another chronic pathology causing fatigue.
Participants in vaso-occlusive crisis (VOC) or hospitalization.
Participant under legal protection (guardianship, curatorship, safeguard of justice, deprived of liberty).

Research Team

Michalina DANNOUNE

Damien OUDIN-DOGLIONI, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Adapting the FACETS Fatigue Management Program for Adults with Sickle Cell Disease

On this page

AI-Summary

What this Trial Is About

Brief Title

Who Can Participate

Eligibility Criteria

Research Team

Not the Right Trial for You?

On this page

Who Can Participate

Eligibility Criteria